Conditions: Osteoarthritis
Keywords: Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1030
Healthy volunteers: no

Brief summary:
The purpose of this phase III study is to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Patients with Osteoarthritis of the Knee

Detailed description:

Arms:
arm 1: SMC021 Oral Calcitonin arm 2: SMC021 Placebo

Interventions: intervention 1: Oral Salmon Calcitonin intervention 2: Oral Salmon Calcitonin (Placebo)
Intervention descriptions: intervention 1: 0.8mg SMC021, twice daily intervention 2: 0.8mg Placebo, twice daily

Protocol document: